Oct 3
|
Immuron Full Year 2024 Earnings: AU$0.03 loss per share (vs AU$0.017 loss in FY 2023)
|
Sep 24
|
Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
|
May 7
|
Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now
|
May 7
|
Immuron Limited to Present at the Emerging Growth Conference
|
Jan 16
|
Immuron achieves record half yearly Travelan® sales
|
Dec 22
|
Immuron Clinical Trials Update
|
Dec 4
|
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
|
Nov 28
|
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
|
Aug 23
|
Planet MicroCap Review Magazine for Summer 2023 Now Online
|
May 2
|
Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
|